PDE4A and chronic obstructive pulmonary disease: PDE4 has been demonstrated to be a promising drug target for the treatment of chronic obstructive pulmonary disease (COPD), asthma, rheumatoid arthritis, lupus, atopic dermatitis, psoriasis, and neurological disorders [2,3].